Management of novel therapeutics' side effects: a nurse-centric model.
Davies
Marianne J
MJ
Yale University School of Medicine, Section of Medical Oncology, Yale Cancer Center, New Haven, CT, USA.
D000970:Antineoplastic Agents / Q000009:adverse effects; D001897:Boronic Acids / Q000009:adverse effects; D000069286:Bortezomib; D016903:Drug Monitoring; D006801:Humans; D000077269:Lenalidomide; D016294:Models, Nursing; D009369:Neoplasms / Q000150:complications / Q000628:therapy*; D024802:Nurse's Role; D009730:Nursing Assessment; D009859:Oncology Nursing / Q000458:organization & administration*; D010344:Patient Advocacy; D010353:Patient Education as Topic; D011719:Pyrazines / Q000009:adverse effects; D013792:Thalidomide / Q000009:adverse effects / Q000031:analogs & derivatives